Chlorobenzene

Chlorobenzene

SCHEMBL290137

Clc1ccccc1.OBO

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.73
▸ CYP1A2 P05177 1/20 0.50
▸ CES2 O00748 1/20 0.46
▸ CES1 P23141 1/20 0.46
▸ ORAI1 Q96D31 1/20 0.46
▸ ORAI2 Q96SN7 1/20 0.46
▸ ORAI3 Q9BRQ5 1/20 0.46
▸ TRPV6 Q9H1D0 1/20 0.46
▸ LMNA P02545 4/20 0.44
▸ CYP2A6 P11509 1/20 0.44
▸ ALOX15 P16050 1/20 0.39
▸ BBOX1 O75936 1/20 0.38
▸ EHMT2 Q96KQ7 1/20 0.38
▸ EHMT1 Q9H9B1 1/20 0.38
▸ MAPT P10636 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ NOX1 Q9Y5S8 1/20 0.38
▸ NR4A1 P22736 1/20 0.38
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chlorobenzene SCHEMBL1331798 0.86 — —
Chlorobenzene SCHEMBL1330702 0.86 — —
Chlorobenzene SCHEMBL1568605 0.86 TSHR (1.00) TSHRCYP1A2CES2CES1ORAI1
Chlorobenzene SCHEMBL9721018 0.86 TSHR (1.00) TSHRCYP1A2CES2CES1ORAI1
Chlorobenzene SCHEMBL11220629 0.86 TSHR (1.00) TSHRCYP1A2CES2CES1ORAI1
SCHEMBL24715429 0.86 TSHR (1.00) TSHRCYP1A2CES2CES1ORAI1
Chlorobenzene SCHEMBL2168046 0.86 TSHR (1.00) TSHRCYP1A2CES2CES1ORAI1
Chlorobenzene SCHEMBL2044 0.86 — —
Chlorobenzene SCHEMBL1339852 0.86 — —
Chlorobenzene SCHEMBL1330516 0.86 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113621215-B Preparation method of organic-inorganic hybrid biomass phenolic resin ablation-resistant material 哈尔滨工业大学 2024-02-09 — — CN claimed
CN-111004149-B Method for preparing polyfluorobenzonitrile by catalytic fluorination of polychlorinated benzonitrile 大连奇凯医药科技有限公司 2022-06-07 — — CN claimed
CN-110483291-B Synthesis method of (E) -beta-aryl-beta, gamma-unsaturated ester compound 安阳师范学院 2021-09-10 — — CN claimed
CN-111253234-A Method for synthesizing biphenyl compounds by taking suaeda salsa extract liquid as solvent 遵义医科大学 2020-06-09 — — CN claimed
US-12612371-B2 Sigma-1 receptor ligands and therapeutic uses thereof UNIVERSITE DE STRASBOURG (FR) 2026-04-28 — — US disclosed
US-20250176425-A1 ELECTROACTIVE COMPOUNDS AND ELECTROLUMINESCENT DEVICE COMPRISING THE SAME U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2025-05-29 — — US disclosed
CN-118198352-A Modification method of high-nickel ternary positive electrode material and preparation method of high-nickel ternary positive electrode plate 昆明理工大学 2024-06-14 — — CN disclosed
CN-113209066-B Amino-aryl-benzamide compounds and methods of use thereof 上海赫普化医药技术有限公司 2024-05-10 — — CN disclosed
EP-4076456-B1 SIGMA-1 RECEPTOR LIGANDS AND THERAPEUTIC USES THEREOF UNIV STRASBOURG (FR) 2024-05-01 — — EP disclosed
US-11964944-B2 Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases THE UNIVERSITY OF CHICAGO (US) 2024-04-23 — — US disclosed
US-20240050430-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC. 2024-02-15 — — US disclosed
EP-4267591-A2 ORGANOMETALLIC COMPOUNDS Umicore AG & Co. KG (DE) 2023-11-01 — — EP disclosed
EP-0691966-A1 QUINOLINES AS TYPE IV PHOSPHODIESTERASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1996-01-17 — — EP disclosed
EP-0583383-B1 LIQUID DETERGENTS WITH AN ARYL BORONIC ACID PROCTER & GAMBLE (US) 1995-12-13 — — EP disclosed
US-5475003-A Antiinflammatory agent, immunosuppressive, antiallergens, bronchodilators, analgens SYNTEX (U.S.A.) INC. (US) 1995-12-12 — — US disclosed
US-5472628-A Aryl boronic acid THE PROCTER & GAMBLE COMPANY (US) 1995-12-05 — — US disclosed
US-5455252-A Antiinflammatory agent, immunosuppressant, antiallergen, skin disorders, bronchodilator, analgesic SYNTEX (U.S.A.) INC. (US) 1995-10-03 — — US disclosed
WO-1994022852-A1 QUINOLINES AS TYPE IV PHOSPHODIESTERASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1994-10-13 — — WO disclosed
EP-0583383-A1 LIQUID DETERGENTS WITH AN ARYL BORONIC ACID. PROCTER & GAMBLE (US) 1994-02-23 — — EP disclosed
WO-1992019707-A1 LIQUID DETERGENTS WITH AN ARYL BORONIC ACID THE PROCTER & GAMBLE COMPANY (US) 1992-11-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12612371-B2 Sigma-1 receptor ligands and therapeutic uses thereof SIGMAR1, OPRL1, OPRM1 TSHR 251/4885CYP1A2 532/4885CES2 455/4885
US-11964944-B2 Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases TUBB1, MYADM, TUBB TSHR 4767/4885CYP1A2 504/4885CES2 736/4885
US-20240050430-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME KRAS, NRAS, HRAS TSHR 4359/4885CYP1A2 4727/4885CES2 4882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback